Gestational diabetes, inflammation, and late vascular disease

Journal of Endocrinological Investigation

Volumn 30, Issue 10, 2007, Pages 873-879

  Volpe, L ^a   Di Cianni, G ^a   Lencioni, C ^a   Cuccuru, I ^a   Benzi, L ^a   Del Prato, S ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Cardiovascular disease; Gestational diabetes; Metabolic syndrome; Subclinical inflammation; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INSULIN; TUMOR NECROSIS FACTOR ALPHA;

BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEMALE; HUMAN; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEDLINE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PREDICTION; PREGNANCY DIABETES MELLITUS; REVIEW; AGE; AGING; DIABETIC ANGIOPATHY; IMMUNOLOGY; METABOLISM; PREGNANCY;

AGE FACTORS; AGING; CARDIOVASCULAR DISEASES; DIABETES, GESTATIONAL; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; INFLAMMATION; PREGNANCY;

EID: 38449117731     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349231     Document Type: Review

References (50)

1. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005, 115: 485-91.
2. Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002, 161: 233-42.
3. Sjöholm Ä, Nyström T. Inflammation and etioliogy of type 2 diabetes. Diabetes Metab Res Rev 2006, 22: 4-10.
4. Wolf M, Sauk J, Shah A, et al. Inflammation and glucose in-tolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 2004, 27: 21-7.
5. Hanley AJG, Festa A, D'Agostino RB, et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 2004, 53: 1773-81.
6. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev 2003, 19: 259-70.
7. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002, 51: 3391-9.
8. Hotamisligil GS. The role of TNFα and TNF receptors in obesity and insulin resistance. J Intern Med 1999, 245: 621-5.
9. Shetty GK, Economidies PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27: 2450-7.
10. Marfella R, Esposito K, Siniscalchi M, et al. Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care 2004, 27: 47-52.
11. Pickup OC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27: 813-23.
12. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342: 836-43.
13. Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 2004, 19: 1025-30.
14. Leopold H, Worda C, Gruber CJ, Prikoszovich T, Wagner O, Kautzky-Willer A. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester. Eur J Clinl Invest 2005, 35: 752-7.
15. Bo S, Signorile A, Menato G, et al. C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest 2005, 28: 779-86.
16. Wolf M, Sandler L, Hsu K, Vossen-Smimakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003, 26: 819-24.
17. Retnakaran R, Hanley AJG, Raif N, Connely PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clinical Endocrinol Metab 2003, 88: 3507-12.
18. Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol 2004, 18: 377-84.
19. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 2002, 51: 2207-13.
20. Kinalski M, Telejko B, Kuzmicki M, Kretowski A, Kinalska I. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 2005, 37: 450-4.
21. Chang Y, Niu XM, Qi XM, Zhang HY, Li NJ, Luo Y. Study on the association between gestational diabetes mellitus and tumor necrosis factor-alpha gene polymorphism. Zhonghua Fu Chan Ke Za Zhi 2005, 40: 676-8.
22. McLachlan KA, O'Neal D, Jenkins A, Alford FP. Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev 2006, 22: 131-8.
23. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003, 26: 2442-50.
24. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectomia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86: 1930-5.
25. Fernandez-Real JM, Castro A, Vazquez G, et al. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 2004, 27: 739-45.
26. Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361: 226-8.
27. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004, 27: 799-800.
28. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knöfler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004, 191: 2120-4.
29. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004, 83: 341-7.
30. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004, 89: 2306-11.
31. Lappas M, Yee K, Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 2005, 186: 457-65.
32. Coughlan MT, Oliva K, Georgiou HM, Permezel JM, Rice GE. Glucose-induced release of tumor necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 2001, 18: 921-7.
33. Lappas M, Permezel M, Rice GE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 2004, 89: 5627-33.
34. Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, GE Rice. Altereted placenta oxidative stress status in gestational diabetes mellitus. Placenta 2004, 25: 78-84.
35. Radaelli I, Varastehpuor A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003, 52: 2951-8.
36. Lencioni C, Volpe L, Miccoli R, et al. Early impairment of β-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes. Nutr Metab Cardiovasc Dis 2006, 16: 485-93.
37. Kahan R, Buse J, Ferrannini F, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28: 2289-304.
38. Ridker PM, Wilson P, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004, 109: 2818-25.
39. Noussitou P, Monbaron D, Vial Y, Gaillard RC, Ruiz J. Gestational diabetes mellitus and the risk of metabolic syndrome: a population-based study in Lausanne, Switzerland. Diabetes Metab 2005, 31: 361-9.
40. Verma A, Boney CM, Tucker R, Vohr BR. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002, 87: 3227-35.
41. Di Cianni G, Lencioni C, Volpe L, et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007, 23: 135-40.
42. Winzer C, Wagner O, Shneider B, et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004, 27: 1721-7.
43. Di Benedetto A, Russo GT, Corrado F, et al. Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Invest 2005, 28: 34-8.
44. Heitritter SM, Solomon CG, Mitchell Gf, Skafi-Ounis N, Seely EW. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2005, 90: 3983-8.
45. Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A. Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care 2002, 25: 560-4.
46. Hannemann MM, Liddell WG, Shore AC, Clark PM, Tooke JE. Vascular function in women with previous gestational diabetes mellitus. J Vasc Res 2002, 39: 311-9.
47. Bo S, Valpreda S, Menato G, et al. Should we consider gestational diabetes a vascular risk factor? Atherosclerosis 2006, in press.
48. Kautzky-Willer A, Fasching P, Jilma B, Waldhäusl W, Wagner OF. Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J Clin Endocrinol Metab 1997, 82: 4117-21.
49. Lawrence NJ, Kousta E, Penny A, et al. Elevation of soluble E-selectin levels following gestational diabetes is restricted to women with persistent abnormalities of glucose regulation. Clin Endocrinol 2002, 56: 335-40.
50. Loukovaara MJ, Loukovaara S, Leinonen PJ, Teramo KA, Andersson SH. Endothelium-derived nitric oxide metabolites and soluble intercellular adhesion molecule-1 in diabetic and normal pregnancies. Eur J Obst Gynecol Reprod Biol 2005, 118: 160-5.